AstraZeneca Applies For EU Approval Of COVID-19 Vaccine
UK’s Controversial Dosing Schedule For Pfizer/BioNTech Jab May Face Legal Scrutiny
The European Medicines Agency may issue an opinion on approving AstraZeneca’s COVID-19 vaccine by 29 January if the data are robust and complete and any additional data requests are dealt with promptly.
